Campaign Chemistry: IPG Health CEO Dana Maiman

Maiman shares what’s new since the IPG Health consolidation last year, how health and pharma brands are evolving creative and media investment strategies and dives into past work on health equity.

by Alison Weissbrot

For full access to this article, you must be a Campaign US subscriber.

Click here to view our subscription options, which now include access to the 2023 Agency Performance Review — a comprehensive analysis of agency business in the past year.

If you are already a subscriber and can't see this article: Click here to activate your subscription.

For support, please email: campaignusa.support@haymarketmedia.com or call (800) 381-0891.

Sign in

Become a member

From $169 a year

  • Full access to campaignlive.com
  • Exclusive event discounts
  • Plus lots more...

Choose a package

Custom Pricing for Group Subscriptions

  • Get company-wide access for your team, department or entire organization.

Contact Us for Rates

Need to activate  your membership?